Melinta Therapeutics, LLC

NJ · United States · Reporting entity ID 100000196838

Total reported 2019–2025

$8.46M

#546 of 2,960 reporting companies — 0% of all reported industry payments

$3.67M in general payments across 41,842 records, plus $4.79M in research funding across 496 records.

How it breaks down

General payments $3,671,780

Research funding $4,788,141

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.